4QMn compound is subjected to several patents: “Metallic complexes mimetic of SOD” (Spain 2355784B1, WO WO2011/033163, United States 9.145.386, Europe 2492270); “Use of SOD mimetic metal complexes as food agents and as cosmetic, patent addition” (Spain 2543850B1, WO WO2015/124824, United States US9.570.677); and “New European 4Q application and autophagy for neurodegenerative diseases” (Europe PCT-07877, WO PCT/EP2018/068010). This evidence concerns the gene SOD1 and neurodegenerative disease.